← Back to Bills
HR 7218118th CongressFailed / ExpiredHouse

BOLD Infrastructure for Alzheimer's Reauthorization Act of 2024

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
May 27, 2025
Latest Action Date
Dec 11, 2024

Latest Action

Became Public Law No: 118-142.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The BOLD Infrastructure for Alzheimer's Reauthorization Act of 2024 is a legislative measure aimed at continuing and potentially expanding federal efforts to address Alzheimer's disease. Although the official summary and full text are not provided, the bill's title and policy area indicate a focus on health infrastructure related to Alzheimer's, likely involving research, care, and support services. The bill was introduced in the House during the 118th Congress and ultimately became Public Law No: 118-142 on December 11, 2024, indicating it was enacted into law despite the status field indicating 'Failed / Expired,' which may reflect a data inconsistency.

Bottom Line

This bill reauthorizes federal initiatives to support Alzheimer's disease infrastructure, reflecting ongoing legislative attention to this public health issue, and was enacted into law in late 2024.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill pertains to the reauthorization of infrastructure programs related to Alzheimer's disease.
  • It was introduced in the House during the 118th Congress and became Public Law No: 118-142 on December 11, 2024.
  • The policy area is health, indicating a focus on medical, caregiving, or research infrastructure for Alzheimer's.
Who Benefits?

["Individuals affected by Alzheimer's disease and their families", "Federal health agencies involved in Alzheimer's research and care", "Healthcare providers and organizations specializing in Alzheimer's disease", 'Researchers and institutions focused on neurodegenerative diseases']

Potential Concerns

['The absence of detailed bill text and summary limits clarity on specific provisions and funding mechanisms.', 'Implementation challenges may arise depending on the scope and scale of authorized programs.', 'Oversight and accountability mechanisms are unclear without full legislative text.', 'Potential costs and budgetary impacts are not specified.']

Political Context

The bill was introduced and passed during the 118th Congress, reflecting bipartisan recognition of Alzheimer's disease as a significant public health issue. The enactment as Public Law No: 118-142 suggests legislative agreement on continuing federal support for Alzheimer's infrastructure. The discrepancy between the 'Failed / Expired' status and the latest action indicates possible data reporting issues.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

["Continued federal support may enhance research and care infrastructure, potentially improving outcomes for Alzheimer's patients.", 'Healthcare systems may see increased demand for specialized services as infrastructure expands.', 'Funding allocations could influence priorities within federal health agencies.']

GovScope Watchdog Notes

The lack of an official bill summary and full text limits comprehensive analysis and public understanding. The conflicting status information should be clarified to ensure transparency about the bill's legislative outcome. Oversight mechanisms and funding details are critical for evaluating the bill's effectiveness and should be made publicly accessible.

Passage Likelihood: HighConfidence: 75%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready